Free Trial
ASX:ACL

Australian Clinical Labs (ACL) Stock Price, News & Analysis

Australian Clinical Labs logo

About Australian Clinical Labs Stock (ASX:ACL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
A$728.27 million
P/E Ratio
30.38
Dividend Yield
3.28%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ACL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Australian Clinical Labs and its competitors with MarketBeat's FREE daily newsletter.

ACL Stock News Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Leadership Transition at Australian Clinical Labs
See More Headlines

ACL Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Australian Clinical Labs investors own include Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU), Coles Group (COL) and VelocityShares 1x Long VSTOXX Futures ETN (EVIX).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
ASX:ACL
CIK
N/A
Fax
N/A
Employees
5,115
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A$0.12
Trailing P/E Ratio
30.38
Forward P/E Ratio
N/A
P/E Growth
-0.36
Net Income
A$23.93 million
Net Margins
3.45%
Pretax Margin
N/A
Return on Equity
13.98%
Return on Assets
6.67%

Debt

Debt-to-Equity Ratio
174.00
Current Ratio
0.64
Quick Ratio
0.53

Sales & Book Value

Annual Sales
A$696.37 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
A$0.89 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
201,830,000
Free Float
N/A
Market Cap
A$728.27 million
Optionable
Not Optionable
Beta
1.18
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (ASX:ACL) was last updated on 7/28/2025 by MarketBeat.com Staff
From Our Partners